Inferahealth
Delaware corporation · 1 known investors
Infera builds a compliance and quality engineering platform for medical device manufacturers, using AI agents to automate regulatory and quality processes. The platform serves medtech teams bringing life-saving devices to market.
Founders & leadership
CB
Charles BlumsackExecutive Officer, Director
AH
Amanda HersonDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.6MofferedMar 2025 · 5 investors · OtherRule 506(b)
▶$2.6MofferedMar 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Charles BlumsackExecutive Officer, Director
- Amanda HersonDirector
- Offering amount
- $2.6M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.